Hyo‐Soo Kim

Active 1997–2026

Also published as
Hyo-Soo Kim · Hyo Soo Kim
223
Papers
32,126
Citations
96
h-index
206
i10-index

Citations

Citations per year for Hyo‐Soo Kim1991: 2 citations1993: 1 citations1994: 1 citations1998: 7 citations1999: 8 citations2000: 15 citations2001: 20 citations2002: 20 citations2003: 43 citations2004: 68 citations2005: 103 citations2006: 120 citations2007: 123 citations2008: 173 citations2009: 172 citations2010: 187 citations2011: 196 citations2012: 197 citations2013: 206 citations2014: 223 citations2015: 207 citations2016: 188 citations2017: 186 citations2018: 181 citations2019: 661 citations2020: 853 citations2021: 858 citations2022: 718 citations2023: 537 citations2024: 956 citations2025: 491 citations2026: 25 citations1992: no citations, so this year is not shown1995–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,356 citing papers, 19.7% of this breakdownChina: 1,097 citing papers, 9.2% of this breakdownItaly: 815 citing papers, 6.8% of this breakdownUnited Kingdom: 766 citing papers, 6.4% of this breakdownSouth Korea: 690 citing papers, 5.8% of this breakdownGermany: 610 citing papers, 5.1% of this breakdownJapan: 485 citing papers, 4.1% of this breakdownNetherlands: 477 citing papers, 4% of this breakdownFrance: 438 citing papers, 3.7% of this breakdownCanada: 405 citing papers, 3.4% of this breakdownSwitzerland: 336 citing papers, 2.8% of this breakdownSpain: 306 citing papers, 2.6% of this breakdown
0%19.7%Other 26.4%

Fields

  • Medicine74.4%
  • Biochemistry, Genetics and Molecular Biology16.7%
  • Immunology and Microbiology2.5%
  • Neuroscience2%
  • Engineering1.7%
  • Materials Science0.9%
  • Other1.8%

Topics

  • Coronary Interventions and Diagnostics8.5%
  • Cardiac Imaging and Diagnostics6.4%
  • Acute Myocardial Infarction Research5.4%
  • Antiplatelet Therapy and Cardiovascular Diseases4.6%
  • Mesenchymal stem cell research2.7%
  • Angiogenesis and VEGF in Cancer2.5%
  • Other69.9%

Coauthors

All papers

Open in search
  1. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ute Windhoevel, Robert W. Yeh, Mitchell W. Krucoff, Marie-Claude Morice - Circulation 2019 cited by 796

  2. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2017 cited by 1,147

  3. Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation

    Authors: , , , , , , , , - Nature Chemical Biology 2019 cited by 193

  4. P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2023 cited by 177

  5. Diagnosis of Ischemia-Causing Coronary Stenoses by Noninvasive Fractional Flow Reserve Computed From Coronary Computed Tomographic Angiograms

    Authors: , , , , , , , , , , - Journal of the American College of Cardiology 2011 cited by 1,264

  6. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ute Windhoevel, Robert W. Yeh, Mitchell W. Krucoff, Marie-Claude Morice - European Heart Journal 2019 cited by 572

  7. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Seung‐Ho Hur, Junghan Yoon, Tae‐Ho Park, Bum Soo Kim, Sang Wook Lim, Yoon Haeng Cho, Dong Woon Jeon, Sang‐Hyun Kim, Jung‐Kyu Han, Eun‐Seok Shin, Hyo‐Soo Kim, Kyoo-Rok Han, Keon‐Woong Moon, Seok Oh, Ung Kim, Moo‐Yong Rhee, Doo‐Il Kim, Song‐Yi Kim, Sungyun Lee, Seung Uk Lee, Sang-Wook Kim, Seok Yeon Kim, Hui-Kyung Jeon, Kwang Soo, Sang‐Ho Jo, Jae Kean Ryu, Il‐Woo Suh, Hyun-Hee Choi, Seoung-Il Woo, In‐Ho Chae, Won‐Yong Shin, Dae-Kyeong Kim, Ju Hyeon Oh, Myung Ho Jeong, Yong Hoon Kim - The Lancet 2021 cited by 353

  8. Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JACC. Cardiovascular imaging 2018 cited by 314

  9. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Harrington, J. Wouter Jukema, Michael Szarek, Harvey D. White, Andreas M. Zeiher, Pierluigi Tricoci, Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina Gotcheva, Juan Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Željko Reiner, Petr Ostadal, Margus Viigimaa, Markku S. Nieminen, Vakhtang Chumburidze, Nikolaus Marx, Nicolas Danchin, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, K. Yusoff, Gabriel Arturo Ramos López, Marco Alings, Sigrun Halvorsen, Roger M. Correa Flores, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H Asita de Silva, Emil Hagström, Ulf Landmesser, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Robert A. Vogel and 1,603 more - The Lancet Diabetes & Endocrinology 2019 cited by 328

  10. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Diaz, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lopes, Nina Gotcheva, Shaun G. Goodman, Juan-Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ošťádal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung-Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang-Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M. Correa Flores, Rody G. Sy, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen D. Ristic, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Matthew T. Roe, Robert A. Vogel, Bernard Chaitman and 1,652 more - Journal of the American College of Cardiology 2021 cited by 141

  11. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Díaz, Philip E Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina N Gotcheva, Shaun G. Goodman, Juan Carlos Prieto, Huo Yong, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ostadal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos, Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo-Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M Correa Flores, Rody G. Sy, Andrzej Budaj, João Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Ján Murín, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty and 1,635 more - Circulation 2022 cited by 122

  12. Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2016 cited by 438

  13. Effects of Ultra-high doserate FLASH Irradiation on the Tumor Microenvironment in Lewis Lung Carcinoma: Role of Myosin Light Chain

    Authors: , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2020 cited by 104

  14. Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hans Lanz, Cathy Chen, Marco Valgimigli, Roland Veltkamp, Shigeru Saito, George D. Dangas - New England Journal of Medicine 2021 cited by 264

  15. Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 153

  16. Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study

    Authors: , , , , , , , , , , , , - Circulation 2022 cited by 151

  17. Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9

    Authors: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2019 cited by 99

  18. Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Minglei Liu, Gregg W. Stone - New England Journal of Medicine 2020 cited by 285

  19. Adenylyl Cyclase-Associated Protein 1 Is a Receptor for Human Resistin and Mediates Inflammatory Actions of Human Monocytes

    Authors: , , , , , , , , , , , , , , - Cell Metabolism 2014 cited by 270

  20. Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non‐Obstructive Coronary Arteries

    Authors: , , , , , , , , , , , , - Journal of the American Heart Association 2019 cited by 154

  21. Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 316

  22. Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shingo Kuwata, Gerald Yong, Hsien‐Li Kao, Michael Lee, Hyo-Soo Kim, Thomas Modine, S. Chiu Wong, Francesco Bedgoni, Luca Testa, Emmanuel Teíger, Christian Butter, Stephan Ensminger, Ulrich Schäfer, Danny Dvir, Philipp Blanke, Jonathon Leipsic, Fabian Nietlispach, Mohamed Abdel‐Wahab, Bernard Chevalier, Corrado Tamburino, David Hildick‐Smith, Brian Whisenant, Seung‐Jung Park, Antonio Colombo, Azeem Latib, Susheel Kodali, Jeroen J. Bax, Lars Søndergaard, John G. Webb, Thierry Lefèvre, Martin B. Leon, Raj Makkar - Journal of the American College of Cardiology 2017 cited by 477

  23. Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 684

  24. Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis

    Authors: , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2003 cited by 1,189